Analyst Activity – BMO Capital Markets Raises Its Price Target On NASDAQ:RIGL – Rigel Pharmaceuticals (NASDAQ:RIGL) to $10.00

ME Staff
-
0

Analyst Ratings For NASDAQ:RIGL – Rigel Pharmaceuticals (NASDAQ:RIGL)

Today, BMO Capital Markets raised its price target on NASDAQ:RIGL – Rigel Pharmaceuticals (NASDAQ:RIGL) to $10.00 per share.

Some recent analyst ratings include

  • 8/3/2016-JPMorgan Chase Reiterated Rating of Buy.

Recent Insider Trading Activity For NASDAQ:RIGL – Rigel Pharmaceuticals (NASDAQ:RIGL)
NASDAQ:RIGL – Rigel Pharmaceuticals (NASDAQ:RIGL) has insider ownership of 5.38% and institutional ownership of 92.11%.

  • On 4/20/2018 Anne-Marie Duliege, EVP, sold 5,000 with an average share price of $4.11 per share and the total transaction amounting to $20,550.00.
  • On 11/3/2017 Ryan D Maynard, CFO, sold 100,000 with an average share price of $3.90 per share and the total transaction amounting to $390,000.00.
  • On 7/5/2017 Anne-Marie Duliege, Insider, sold 5,000 with an average share price of $2.69 per share and the total transaction amounting to $13,450.00.
  • On 8/30/2016 Donald G Payan, EVP, sold 5,303 with an average share price of $4.00 per share and the total transaction amounting to $21,212.00.
  • On 4/1/2015 Donald G Payan, EVP, sold 10,000 with an average share price of $3.75 per share and the total transaction amounting to $37,500.00.
  • On 12/18/2014 Dolly Vance, EVP, sold 1,000 with an average share price of $2.22 per share and the total transaction amounting to $2,220.00.
  • On 9/3/2014 Donald G Payan, EVP, sold 20,000 with an average share price of $2.56 per share and the total transaction amounting to $51,200.00.

Recent Trading Activity for NASDAQ:RIGL – Rigel Pharmaceuticals (NASDAQ:RIGL)
Shares of NASDAQ:RIGL – Rigel Pharmaceuticals closed the previous trading session at 3.91 up +0.21 5.68% with 2796769 shares trading hands.